Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Heart Failure
Interventions
DEVICE

The Jarvik 2000 Ventricular Assist System

Jarvik 2000 Heart implantation is intended for patient's with end-stage heart failure who are approved heart transplant candidates - who meet all of the study's inclusion criteria and none of its exclusion criteria.

Trial Locations (1)

21201

University of Maryland Medical Center, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Jarvik Heart, Inc.

INDUSTRY